Fibroids Symptoms Pain
Neurocrine Biosciences’ Endometriosis Drug Meets Trial Goals In Mid-stage Study
Shares of Neurocrine Biosciences Inc. (NBIX) rose over 48% in late trading Monday after the company reported statistically significant and clinically meaningful top-line efficacy results from a mid-stage trial of its investigational drug Elagolix, in patients with endometriosis.
Non-Invasive Treatment of Uterine Fibroids in New York